WeVote

Bill

Bill

S 1497

An Act protecting patient safety regarding non-FDA approved drugs

194th Legislature (2025-2026) Introduced by John Cronin

Massachusetts bill establishes state-level patient safety regulations for prescribing and dispensing non-FDA approved drugs to protect patients from potential harms.

Referred to the committee on Senate Ways and Means
0
WeVote Research Nonpartisan
Bill Summary · S 1497

Legislative bill overview

S 1497 establishes patient safety protections regarding the use of non-FDA approved drugs in Massachusetts. The bill creates regulatory requirements and oversight mechanisms for prescribing, dispensing, and monitoring non-FDA approved medications to ensure patient safety standards are maintained.

Why is this important

Non-FDA approved drugs—including compounded medications, drugs approved in other countries but not the U.S., and experimental treatments—exist in a regulatory gray area that can pose safety risks if used without proper safeguards. This bill addresses a real gap in patient protection by establishing state-level oversight for drugs that fall outside federal FDA approval frameworks, which is particularly relevant for vulnerable patients seeking alternative treatments.

Potential points of contention

  • Access vs. safety trade-off: Stricter regulations may limit patient access to non-FDA approved drugs that some individuals believe are beneficial, creating tension between safety mandates and patient autonomy/right to try
  • Physician autonomy concerns: Medical providers may resist requirements that they view as government overreach into clinical decision-making and doctor-patient relationships
  • Definition and scope ambiguity: The bill's specific definitions of which drugs are covered, what safety requirements apply, and enforcement mechanisms remain unclear from the summary and could impact compounding pharmacies, international drug importation, and off-label prescribing differently

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.